Patent · US Active

Compositions and methods for treating EZH2-mediated cancer

US11510920B2 · kind B2 · utility

0Cited by

5References

10Claims

0Family size

Assignee

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · US

Inventors

Jian Jin · Suzhou, CN
Ramon Parsons · Manhasset, US
Ilias Stratikopoulos · New York, US
Xiaobao Yang · New York, US
Anqi Ma · New York, US

Key dates

Filing date	Jul 10, 2020
Grant date	Nov 29, 2022
Priority date	—
Expiry date	Jul 10, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for designing bivalent compounds which selectively degrade/disrupt EZH2 and compositions and methods of using such degraders/disruptors to treat EZH2-mediated cancer are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.